ROS-1 TKI for the treatment of concurrent sarcomatoid transformation and acquired ROS-1 F2004C mutation in a lung adenocarcinoma patient

• H.-J. Ko,
• C.-K. Hsu,
• Y.-C. Yeh,
• H.-C. Huang

Affiliations

H.-J. Ko

Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

C.-K. Hsu

Department of Internal Medicine, Mennonite Christian Hospital, Hualien, Taiwan

Y.-C. Yeh

Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taiwan

H.-C. Huang

Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taiwan; Corresponding author at: Department of Chest Medicine, Taipei Veterans General Hospital; 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan.